Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

312 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Is neuroblastoma screening evaluation needed and feasible?
Estève J, Parker L, Roy P, Herrmann F, Duffy S, Frappaz D, Lasset C, Hill C, Sancho-Garnier H, Michaelis J, et al. Estève J, et al. Among authors: frappaz d. Br J Cancer. 1995 Jun;71(6):1125-31. doi: 10.1038/bjc.1995.219. Br J Cancer. 1995. PMID: 7779698 Free PMC article. Review.
Comparison of the diagnostic and prognostic value of biological markers in neuroblastoma. Proposal for a common methodology of analysis. SENSE group.
Favrot MC, Ambros P, Schilling F, Frappaz D, Combaret V, Berthold F, Dominici C, Erttmann R, Esteve J, Jenkner A, Kerbl R, Mann J, Mathieu P, Parker L, Powell J, Philip T. Favrot MC, et al. Among authors: frappaz d. Ann Oncol. 1996 Aug;7(6):607-11. doi: 10.1093/oxfordjournals.annonc.a010678. Ann Oncol. 1996. PMID: 8879375 Free article. Review.
[Systematic screening for neuroblastoma].
Frappaz D, Philip T, Chauvin F, Mathieu P, Lasset C, Estève J, Brunat-Mentigny M. Frappaz D, et al. Arch Pediatr. 1995 Oct;2(10):1016-8. doi: 10.1016/0929-693x(96)89902-7. Arch Pediatr. 1995. PMID: 7496460 French. No abstract available.
Screening for neuroblastoma in France: methodological aspects and preliminary observations.
Chauvin F, Mathieu P, Frappaz D, Lasset C, Favrot MC, Greffe J, Esteve J, Thiesse P, Combaret V, Chauvot P, Boschetti R, David L, Brunat-Mentigny M, Philip T. Chauvin F, et al. Among authors: frappaz d. Med Pediatr Oncol. 1997 Feb;28(2):81-91. doi: 10.1002/(sici)1096-911x(199702)28:2<81::aid-mpo1>3.0.co;2-o. Med Pediatr Oncol. 1997. PMID: 8986143
The International Neuroblastoma Risk Groups (INRG): a preliminary report.
Castleberry RP, Pritchard J, Ambros P, Berthold F, Brodeur GM, Castel V, Cohn SL, De Bernardi B, Dicks-Mireaux C, Frappaz D, Haase GM, Haber M, Jones DR, Joshi VV, Kaneko M, Kemshead JT, Kogner P, Lee RE, Matthay KK, Michon JM, Monclair R, Roald BR, Seeger RC, Shaw PJ, Shuster JJ, et al. Castleberry RP, et al. Among authors: frappaz d. Eur J Cancer. 1997 Oct;33(12):2113-6. doi: 10.1016/s0959-8049(97)00202-5. Eur J Cancer. 1997. PMID: 9516864 Review. No abstract available.
312 results